Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?
Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque; Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S. Rouzaud C, et al. Among authors: hautecoeur p. Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. Mult Scler Relat Disord. 2017. PMID: 29141801 No abstract available.
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion.
Calais G, Forzy G, Crinquette C, Mackowiak A, de Seze J, Blanc F, Lebrun C, Heinzlef O, Clavelou P, Moreau T, Hennache B, Zephir H, Verier A, Neuville V, Confavreux C, Vermersch P, Hautecoeur P. Calais G, et al. Among authors: hautecoeur p. Mult Scler. 2010 Jan;16(1):87-92. doi: 10.1177/1352458509352195. Epub 2009 Dec 22. Mult Scler. 2010. PMID: 20028709
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Peyro Saint Paul L, Creveuil C, Heinzlef O, De Seze J, Vermersch P, Castelnovo G, Cabre P, Debouverie M, Brochet B, Dupuy B, Lebiez P, Sartori É, Clavelou P, Brassat D, Lebrun-Frenay C, Daplaud D, Pelletier J, Coman I, Hautecoeur P, Tourbah A, Defer G. Peyro Saint Paul L, et al. Among authors: hautecoeur p. J Neurol Sci. 2016 Apr 15;363:69-76. doi: 10.1016/j.jns.2016.02.012. Epub 2016 Feb 6. J Neurol Sci. 2016. PMID: 27000224 Clinical Trial.
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.
Pignolet B, Schwab N, Schneider-Hohendorf T, Bucciarelli F, Biotti D, Averseng-Peaureaux D, Outteryck O, Ongagna JC, de Sèze J, Brochet B, Ouallet JC, Debouverie M, Pittion S, Defer G, Derache N, Hautecoeur P, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Berger E, Pelletier J, Rico A, Zéphir H, Laplaud D, Wiertlewski S, Camu W, Thouvenot E, Casez O, Moreau T, Fromont A, Vukusic S, Papeix C, Vermersch P, Comabella M, Lebrun-Frenay C, Wiendl H, Brassat D; BIONAT, SFSEP, and BEST-MS networks. Pignolet B, et al. Among authors: hautecoeur p. Neurology. 2016 Dec 6;87(23):2491-2494. doi: 10.1212/WNL.0000000000003401. Epub 2016 Nov 4. Neurology. 2016. PMID: 27815407 Clinical Trial. No abstract available.
Treatment discontinuation in multiple sclerosis: The French Web-based survey ALLIANCE.
Donzé C, Malapel L, Kwiatkowski A, Lenne B, Louchard P, Neuville V, Hautecoeur P. Donzé C, et al. Among authors: hautecoeur p. Mult Scler J Exp Transl Clin. 2015 Aug 19;1:2055217315600720. doi: 10.1177/2055217315600720. eCollection 2015 Jan-Dec. Mult Scler J Exp Transl Clin. 2015. PMID: 28607703 Free PMC article.
The Practice of Sport in Multiple Sclerosis: Update.
Donze C, Massot C, Hautecoeur P, Cattoir-Vue H, Guyot MA. Donze C, et al. Among authors: hautecoeur p. Curr Sports Med Rep. 2017 Jul/Aug;16(4):274-279. doi: 10.1249/JSR.0000000000000374. Curr Sports Med Rep. 2017. PMID: 28696991 Review.
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.
Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D'Hooghe MB, Laplaud DA, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F, Vukusic S; PRIMS and POPARTMUS investigators. Lavie C, et al. Among authors: hautecoeur p. Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20. Mult Scler. 2019. PMID: 31081475 Clinical Trial.
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE).
Camu W, Lehert P, Pierrot-Deseilligny C, Hautecoeur P, Besserve A, Jean Deleglise AS, Payet M, Thouvenot E, Souberbielle JC. Camu W, et al. Among authors: hautecoeur p. Neurol Neuroimmunol Neuroinflamm. 2019 Aug 6;6(5):e597. doi: 10.1212/NXI.0000000000000597. Print 2019 Sep. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31454777 Free PMC article. Clinical Trial.
109 results